Duration of untreated, uncomplicated chlamydia trachomatis genital infection and factors associated with chlamydia resolution: A review of human studies

Journal of Infectious Diseases

Volumn 201, Issue SUPPL. 2, 2010, Pages

  Geisler, William M ^a,b  

^a University of Alabama at Birmingham   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; DISEASE DURATION; GENITAL TRACT INFECTION; HUMAN; IMMUNE RESPONSE; MEDICAL LITERATURE; MEDICAL RESEARCH; NONHUMAN; PRIORITY JOURNAL; REVIEW; SEXUALLY TRANSMITTED DISEASE; FEMALE; GENETICS; GYNECOLOGIC DISEASE; IMMUNOLOGY; MICROBIOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; RISK FACTOR; TIME;

CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; FEMALE; GENITAL DISEASES, FEMALE; HUMANS; RISK FACTORS; TIME FACTORS;

EID: 77953110507     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/652402     Document Type: Review

References (30)

1. Centers for Disease Control and Prevention. Sexually transmitted disease surveillance, 2007. Atlanta, GA: US Department of Health and Human Services, 2008.
2. Hu D, Hook EW III, Goldie SJ. The impact of natural history parameters on the cost effectiveness of Chlamydia trachomatis screening strategies. Sex Transm Dis 2006; 33: 428-1136
3. Miyairi I, Ramsey KH, Patton DL. Duration of untreated chlamydial genital infection and factors associated with clearance: review of animal studies. J Infect Dis 2010; 201 (suppl 2): S96-S103 (in this supplement).
4. Wyrick PB. Chlamydia trachomatis persistence in vitro: an overview. J Infect Dis 2010; 201 (suppl 2): S88-S95 (in this supplement).
5. Haggerty CL, Gottlieb SL, Taylor BD, Low N, Xu F, Ness RB. Risk of sequelae after Chlamydia trachomatis genital infection in women. J Infect Dis 2010; 201 (suppl 2): S134-S155 (in this supplement).
6. Darville T, Hiltke T. Pathogenesis of genital tract disease due to Chlamydia trachomatis. J Infect Dis 2010; 201(suppl 2): S114-S125 (in this supplement).
7. Batteiger B, Xu F, Johnson RE, Rekart ML. Protective immunity to Chlamydia trachomatis genital infection: evidence from human studies. J Infect Dis 2010; 201(suppl 2): S178-S189 (in this supplement).
8. Parks KS, Dixon PB, Richey CM, Hook EW III. Spontaneous clearance of Chlamydia trachomatis infection in untreated patients. Sex Transm Dis 1997; 24: 229-235.
9. Geisler WM, Wang C, Morrison SG, Black CM, Bandea CI, Hook EW III. The natural history of untreated Chlamydia trachomatis infection in the interval between screening and returning for treatment. Sex Transm Dis 2008; 35: 119-123.
10. Joyner JL, Douglas JM Jr, Foster M, Judson FN. Persistence of Chlamydia trachomatis infection detected by polymerase chain reaction in untreated patients. Sex Transm Dis 2002; 29: 196-200.
11. Rogers SM, Miller WC, Turner CF, et al. Concordance of Chlamydia trachomatis infections within sexual partnerships. Sex Transm Infect 2008; 84: 23-28.
12. van den Brule AJ, Munk C, Winther JF, et al. Prevalence and persistence of asymptomatic Chlamydia trachomatis infections in urine specimens from Danish male military recruits. Int J STD AIDS 2002; 13(suppl 2): 19-22.
13. Sheffield JS, Andrews WW, Klebanoff MA, et al. Spontaneous resolution of asymptomatic Chlamydia trachomatis in pregnancy. Obstet Gynecol 2005; 105: 557-562.
14. van Valkengoed IG, Morré SA, van den Brule AJ, et al. Follow-up, treatment, and reinfection rates among asymptomatic Chlamydia trachomatis cases in general practice. Br J Gen Pract 2002; 52: 623-627.
15. McCormack WM, Alpert S, McComb DE, Nichols RL, Semine DZ, Zinner SH. Fifteen-month follow-up study of women infected with Chlamydia trachomatis. N Engl J Med 1979; 300: 123-125.
16. Molano M, Meijer CJ, Weiderpass E, et al. The natural course of Chlamydia trachomatis infection in asymptomatic Colombian women: a 5year follow-up study. J Infect Dis 2005; 191: 907-916.
17. Morré SA, van den Brule AJ, Rozendaal L, et al. The natural course of asymptomatic Chlamydia trachomatis infections: 45% clearance and no development of clinical PID after one-year follow-up. Int J STD AIDS 2002; 13(suppl 2): 12-18.
18. Agrawal T, Vats V, Salhan S, Mittal A. Mucosal and peripheral immune responses to chlamydial heat shock proteins in women infected with Chlamydia trachomatis. Clin Exp Immunol 2007; 148: 461-468.
19. Ghaem-Maghami S, Ratti G, Ghaem-Maghami M, et al. Mucosal and systemic immune responses to plasmid protein pgp3 in patients with genital and ocular Chlamydia trachomatis infection. Clin Exp Immunol 2003; 132: 436-442.
20. Mittal A, Kapur S, Gupta S. Host immune response in chlamydial cervicitis. Br J Biomed Sci 1996; 53: 214-220.
21. Pate MS, Hedges SR, Sibley DA, Russell MW, Hook EW III, Mestecky J. Urethral cytokine and immune responses in Chlamydia trachomatisinfected males. Infect Immun 2001; 69: 7178-7181.
22. Wang C, Tang J, Crowley-Nowick PA, Wilson CM, Kaslow RA, Geisler WM. Interleukin (IL)-2 and IL-12 responses to Chlamydia trachomatis infection in adolescents. Clin Exp Immunol 2005; 142: 548-554.
23. Geisler WM, Yu S, Hook EW III. Chlamydial and gonococcal infection in men without polymorphonuclear leukocytes on gram stain: implications for diagnostic approach and management. Sex Transm Dis 2005; 32: 630-634.
24. Ghanem KG, Shah N, Klein RS, et al. Influence of sex hormones, HIV status, and concomitant sexually transmitted infection on cervicovaginal inflammation. J Infect Dis 2005; 191: 358-366.
25. Mittal A, Rastogi S, Reddy BS, Verma S, Salhan S, Gupta E. Enhanced immunocompetent cells in chlamydial cervicitis. J Reprod Med 2004; 49: 671-677.
26. Cohen CR, Koochesfahani KM, Meier AS, et al. Immunoepidemiologic profile of Chlamydia trachomatis infection: importance of heat-shock protein 60 and interferon- gamma. J Infect Dis 2005; 192: 591-599.
27. Geisler WM, Tang J, Wang C, Wilson CM, Kaslow RA. Epidemiological and genetic correlates of incident Chlamydia trachomatis infection in North American adolescents. J Infect Dis 2004; 190: 1723-2179
28. Wang C, Tang J, Geisler WM, Crowley-Nowick PA, Wilson CM, Kaslow RA. Human leukocyte antigen and cytokine gene variants as predictors of recurrent Chlamydia trachomatis infection in high-risk adolescents. J Infect Dis 2005; 191: 1084-1092.
29. Dean D, Suchland RJ, Stamm WE. Evidence for long-term cervical persistence of Chlamydia trachomatis by omp1 genotyping. J Infect Dis 2000; 182(3): 909-916.
30. Gomes JP, Borrego MJ, Atik B, Santo I, et al. Correlating Chlamydia trachomatis infectious load with urogenital ecological success and disease pathogenesis. Microbes Infect 2006; 8: 16-26.